Evidence map›Paper›PMID 26925318›Full record

ArticlePeerJ2016

Initiating a watch list for Ebola virus antibody escape mutations.

Craig R Miller, Erin L Johnson, Aran Z Burke, Kyle P Martin, Tanya A Miura, Holly A Wichman, Celeste J Brown, F Marty Ytreberg

Abstract read
In one paragraph

Article in PeerJ, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. ThemBio · 2025
    Article
  5. ΦX174 bacteriophage viability predicted by protein biophysical modeling.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Craig R MillerDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States; Department of Mathematics, University of Idaho, Moscow, ID, United States; Center for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States; Institute for Bioinformatics and Evolutionary Studies, University of Idaho, Moscow, ID, United States.
Erin L JohnsonCenter for Modeling Complex Interactions, University of Idaho , Moscow, ID , United States.
Aran Z BurkeCenter for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States; Department of Physics, University of Idaho, Moscow, ID, United States.
Kyle P MartinCenter for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States; Department of Physics, University of Idaho, Moscow, ID, United States.
Tanya A MiuraDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States; Center for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States.
Holly A WichmanDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States; Center for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States; Institute for Bioinformatics and Evolutionary Studies, University of Idaho, Moscow, ID, United States.
Celeste J BrownDepartment of Biological Sciences, University of Idaho, Moscow, ID, United States; Center for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States; Institute for Bioinformatics and Evolutionary Studies, University of Idaho, Moscow, ID, United States.
F Marty YtrebergCenter for Modeling Complex Interactions, University of Idaho, Moscow, ID, United States; Institute for Bioinformatics and Evolutionary Studies, University of Idaho, Moscow, ID, United States; Department of Physics, University of Idaho, Moscow, ID, United States.

Funding

Sequence-structure-function relationships in human visual photopigmentsP20GM104420 · NIGMS · UNIVERSITY OF IDAHO · PI VAN LEUVEN, JAMES · 2015 to 2024
$22.9M
Genomics Resources Core (GRC)P30GM103324 · NIGMS · UNIVERSITY OF IDAHO · PI SETTLES, MATTHEW · 2013 to 2017
$5.0M
NIGMS NIH HHS P20 GM104420NIGMS NIH HHS P30 GM103324
6 · The paper itself

Abstract

The 2014 Ebola virus (EBOV) outbreak in West Africa is the largest in recorded history and resulted in over 11,000 deaths. It is essential that strategies for treatment and containment be developed to avoid future epidemics of this magnitude. With the development of vaccines and antibody-based therapies using the envelope glycoprotein (GP) of the 1976 Mayinga strain, one important strategy is to anticipate how the evolution of EBOV might compromise these efforts. In this study we have initiated a watch list of potential antibody escape mutations of EBOV by modeling interactions between GP and the antibody KZ52. The watch list was generated using molecular modeling to estimate stability changes due to mutation. Every possible mutation of GP was considered and the list was generated from those that are predicted to disrupt GP-KZ52 binding but not to disrupt the ability of GP to fold and to form trimers. The resulting watch list contains 34 mutations (one of which has already been seen in humans) at six sites in the GP2 subunit. Should mutations from the watch list appear and spread during an epidemic, it warrants attention as these mutations may reflect an evolutionary response from the virus that could reduce the effectiveness of interventions such as vaccination. However, this watch list is incomplete and emphasizes the need for more experimental structures of EBOV interacting with antibodies in order to expand the watch list to other epitopes. We hope that this work provokes experimental research on evolutionary escape in both Ebola and other viral pathogens.

Indexed as

EbolaEscape MutationsFoldXMolecular dynamicsProtein stability

Identifiers

PMID26925318
PMCPMC4768679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.